Read + Share
Kazmi F, Nicum S, Roux RL, Spiers L, et al. A Phase IB open-label, dose-escalation study of NUC1031 in combination with
carboplatin for recurrent ovarian cancer. Clin Cancer Res 2021 Mar 19. pii: 1078-0432.CCR-20-4403.
PMID: 33741651
|
 |
|
Kazmi F, Nicum S, Roux RL, Spiers L, et al. A Phase IB open-label, dose-escalation study of NUC1031 in combination with
carboplatin for recurrent ovarian cancer. Clin Cancer Res 2021 Mar 19. pii: 1078-0432.CCR-20-4403.
PMID: 33741651
|
|
|
|